Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancers|January 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast CancerAkshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran, et al.
International Journal of Cancer|February 8, 2022
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional studyMin Jin Ha, Akshara Singareeka Raghavendra, Nicole M Kettner, et al.
NPJ Breast Cancer|January 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancerAkshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski, et al.
Rare Tumors|January 10, 2025
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case reportMeghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, et al.
Molecular Cancer|February 15, 2025
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancerLinjie Luo, Peng Yang, Sofia Mastoraki, et al.
Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, <i>ESR1</i>-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.
NPJ Breast Cancer|August 11, 2023
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecanMing Zhao, Timothy P DiPeri, Maria Gabriela Raso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast CancerArgun Akcakanat, Xiaofeng Zheng, Christian X Cruz Pico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
Cancer Medicine|December 19, 2019
Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancerNaoto T Ueno, Rie K Tahara, Takeo Fujii, et al.
Pageof 5